Table 2 CPET changes
SHAM-Placebo (N = 15) | HBOT (N = 16) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Baseline | SHAM | P value | Baseline | Post-HBOT | P value | Baseline comparison P value | Net effect size | Time X group interaction F(P) | |
Primary endpoint | |||||||||
VO2Max (mL/min) | 2673.33 ± 748.03 | 2631.07 ± 751.31 | 0.14 | 2834.50 ± 556.65 | 2956.19 ± 540.85 | 0.03 | 0.49 | 0.989 [0.210–1.76] | 7.57(0.010)* |
VO2AT (mL/min) | 1210.87 ± 239.80 | 1208.53 ± 266.18 | 0.93 | 1196.56 ± 218.29 | 1326.56 ± 249.11 | 0.01 | 0.86 | 0.837 [0.071–1.604] | 5.43(0.026)* |
Secondary endpoints | |||||||||
Power (watts) | 256.27 ± 66.43 | 254.73 ± 68.25 | 0.78 | 277.37 ± 46.14 | 290.93 ± 51.87 | 0.004* | 0.31 | 0.808 [0.04–1.57] | 5.05(0.03)* |
VO2/Kg (mL/kg/min) | 36.08 ± 9.08 | 35.51 ± 8.85 | 0.15 | 42.00 ± 9.80 | 43.86 ± 9.04 | 0.02 | 0.09 | 1.019[0.238–1.800] | 8.04(0.008)* |
BR (%) | 32.64 ± 12.42 | 36.77 ± 12.05 | 0.14 | 35.71 ± 13.07 | 30.67 ± 15.05 | 0.05 | 0.508 | − 0.91[− 0.168–(− 0.140)] | 6.44(0.016)* |
VO2AT/VO2Max (%) | 46.95 ± 8.98 | 47.25 ± 7.32 | 0.77 | 42.48 ± 4.33 | 45.46 ± 8.29 | 0.15 | 0.08 | 0.424 [− 0.138–1.167] | 1.39 (0.247) |